39
Growth Score in past quarter
pts
Heat Score 39 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3476713
Colonis Pharma develops and commercializes pharmaceuticals for enhancing patient care in healthcare.
About the Company
Colonis Pharma specializes in the development and commercialization of pharmaceutical products aimed at improving patient care in the healthcare sector. With a focus on addressing unmet medical needs, Colonis Pharma offers a range of medications, including Glycopyrronium Bromide Oral Solution, as part of its product portfolio. The company engages
in rigorous research and development to expand its drug pipeline, currently involved in clinical trials to further innovate within its therapeutic areas. Colonis Pharma is committed to providing medical information and support, facilitating adverse drug reaction reporting through platforms like the Yellow Card website.